Endocrine System Diseases  >>  ispinesib (SB-715992)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ispinesib (SB-715992) / Cytokinetics
NCT00097409: Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer

Completed
2
35
US
Ispinesib
GlaxoSmithKline
Ovarian Cancer
05/07
05/07

Download Options